Rescheduled but Not Listed: The Outlook for U.S. Cannabis Companies on Major Exchanges
On April 23, 2026, the Department of Justice and the Drug Enforcement Administration issued an order placing FDA-approved marijuana products and marijuana products subject to a qualifying state-issued medical license in Schedule…